Citigroup
ASXC

Citigroup’s Asensus Surgical, Inc. ASXC Stock Holding History

Citigroup’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,784
Closed -$3K – 7808
2019
Q4 		$3K Sell
1,784
-662
-27% -$2.3K ﹤0.01% 7508
2019
Q3 		$20K Sell
2,446
-785
-24% -$10.7K ﹤0.01% 6747
2019
Q2 		$57K Buy
3,231
+254
+9% +$5.56K ﹤0.01% 6355
2019
Q1 		$92K Sell
2,977
-1,715
-37% -$57.5K ﹤0.01% 5829
2018
Q4 		$138K Sell
4,692
-5,385
-53% -$245K ﹤0.01% 5385
2018
Q3 		$760K Buy
10,077
+5,669
+129% +$384K ﹤0.01% 3795
2018
Q2 		$250K Buy
4,408
+3,377
+328% +$123K ﹤0.01% 4841
2018
Q1 		$23K Sell
1,031
-846
-45% -$19.4K ﹤0.01% 6679
2017
Q4 		$47K Buy
1,877
+1,500
+398% +$46.2K ﹤0.01% 6232
2017
Q3 		$7K Buy
377
+300
+390% +$3.49K ﹤0.01% 6786
2017
Q2 		$1K Buy
+77
New +$732 ﹤0.01% 7224
2017
Q1 		– Sell
-77
Closed -$1K – 7370
2016
Q4 		$1K Sell
77
-92
-54% -$1.89K ﹤0.01% 7140
2016
Q3 		$4K Sell
169
-39
-19% -$713 ﹤0.01% 6834
2016
Q2 		$3K Buy
+208
New +$6.53K ﹤0.01% 6886

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's ASXC Position: Q2 2023 in Review

Citigroup sold out of Asensus Surgical, Inc. (ASXC) in Q2 2023, closing a stake of 3,047 shares — an estimated $2K sold.

Citigroup first reported a position in ASXC in Q2 2014 and held it in 33 quarters. The position peaked at $523K in Q3 2018. 80 funds tracked by Wall St. Rank hold ASXC as of Q2 2023.

  • Citigroup reported no remaining Asensus Surgical, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citigroup sold 3,047 Asensus Surgical, Inc. shares in Q2 2023, an estimated $2K.
  • Citigroup first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 33 quarters.
  • Citigroup's Asensus Surgical, Inc. position peaked at $523K in Q3 2018.
  • 80 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.